1.27
price up icon9.48%   0.11
after-market After Hours: 1.28 0.01 +0.79%
loading

Clearside Biomedical Inc Stock (CLSD) Forecast

The Clearside Biomedical Inc (CLSD) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.1407, representing a -10.18% decrease from the current price of $1.27. The highest analyst price target is $1.4561, and the lowest is $0.8254.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLSD Price Target
Average 2.5131 (+97.88% Upside)
loading

Is Clearside Biomedical Inc (CLSD) A Buy Now?

Oscillators
Name Value Action
RSI(14) 58.91 Neutral
STOCH(9,6) 28.85 Neutral
STOCHRSI(14) 41.87 Neutral
MACD(12,26) 0.031 Sell
ADX(14) 26.83 Buy
William %R -37.93 Neutral
CCI(14) -4.0057 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.223
Buy
1.20
Buy
MA20
1.1739
Buy
1.1774
Buy
MA50
1.1119
Buy
1.1538
Buy
MA100
1.1847
Buy
1.1799
Buy
MA200
1.2725
Sell
1.1841
Buy
Buy: 9 Sell: 1 Neutral: 0
Summary: Buy
According to our latest analysis, CLSD could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 2 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on CLSD, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 58.91 indicates that CLSD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 28.85 indicates that CLSD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 41.87 indicates that CLSD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 26.83 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -4.0057 indicates that CLSD is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term CLSD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Clearside Biomedical Inc financial reports and earnings history, Clearside Biomedical Inc (CLSD) stock could reach $1.46 by 2030, $1.716 by 2040 and $3.2383 by 2050. See the projected annual prices until 2050 of the Clearside Biomedical Inc stock below:

  • Clearside Biomedical Inc (CLSD) is expected to reach an average price of $1.1685 in 2035, with a high prediction of $1.3485 and a low estimate of $0.8434. This indicates an $-7.99% rise from the last recorded price of $1.27.
  • Clearside Biomedical Inc (CLSD) stock is projected to chart a bullish course in 2040, with an average price target of $1.2461, representing an $-1.88% surge from its current level. The forecast ranges from a conservative $1.1479 to a sky-high $1.716.
  • Our analysts predict Clearside Biomedical Inc (CLSD) to jump 30.14% by 2045, soaring from $1.3127 to an average price of $1.6527, potentially reaching $1.7327. While $1.3127 is the low estimate, the potential upside is significant.
  • Clearside Biomedical Inc (CLSD) stock is expected to climb by 2050, reaching an average of $3.0083, a $136.87% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.2383 and $1.6982, respectively, highlighting the market's uncertainty.

Clearside Biomedical Inc Stock (CLSD) Year by Year Forecast

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2024

Our forecast for CLSD stock price in 2024 now indicates an average price target of $1.3796 with a high forecast of $2.12 and a low forecast of $0.6393. The average prediction reflects an increase of +8.63% from the last recorded price of $1.27.
Month Average Low High Change from today's price
November, 2024 $1.2155 $0.8254 $1.4561 -4.29%
December, 2024 $1.7355 $1.0375 $1.9055 +36.66%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2025

Clearside Biomedical Inc Stock (CLSD) is expected to reach an average price of $2.6883 in 2025, with a high prediction of $4.2007 and a low estimate of $1.1759. This indicates an +111.68% rise from the last recorded price of $1.27.
Month Average Low High Change from today's price
January, 2025 $1.9706 $1.5955 $4.0256 +55.17%
February, 2025 $3.8757 $1.8756 $3.9957 +205.17%
March, 2025 $2.2557 $1.9857 $4.2007 +77.62%
April, 2025 $1.7557 $1.1759 $3.3758 +38.25%
May, 2025 $2.2287 $1.5356 $2.6159 +75.49%
June, 2025 $2.0559 $1.8447 $2.4259 +61.89%
July, 2025 $2.046 $1.886 $2.626 +61.10%
August, 2025 $1.8161 $1.7361 $2.1361 +43.00%
September, 2025 $1.8362 $1.6661 $2.1261 +44.58%
October, 2025 $1.6262 $1.5662 $2.0162 +28.05%
November, 2025 $1.6163 $1.5063 $1.9163 +27.27%
December, 2025 $1.4264 $1.3264 $1.6763 +12.31%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2026

The predicted value for Clearside Biomedical Inc (CLSD) in 2026 is set at an average of $4.5768. Estimates vary from a peak of $7.8071 to a trough of $1.3464, indicating an +260.37% surge from the present price of $1.27.
Month Average Low High Change from today's price
January, 2026 $2.0264 $1.3464 $2.1564 +59.56%
February, 2026 $2.1165 $1.7565 $2.4765 +66.65%
March, 2026 $4.0866 $1.9965 $4.3766 +221.78%
April, 2026 $3.9266 $3.0466 $4.6066 +209.18%
May, 2026 $2.8167 $2.7367 $4.3267 +121.79%
June, 2026 $2.7368 $2.2867 $2.8767 +115.49%
July, 2026 $2.4569 $2.3369 $3.3768 +93.45%
August, 2026 $3.0869 $2.3069 $3.3469 +143.06%
September, 2026 $5.587 $3.0869 $7.367 +339.92%
October, 2026 $5.2871 $4.647 $6.207 +316.30%
November, 2026 $6.9671 $4.9371 $7.8071 +448.59%
December, 2026 $6.0572 $5.8772 $7.4172 +376.95%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Clearside Biomedical Inc (CLSD) is $3.8175, with a high forecast of $6.2971 and a low forecast of $1.3379. This indicates an +200.59% increase from the last price of $1.27.
Month Average Low High Change from today's price
January, 2027 $5.8073 $4.8972 $6.2971 +357.27%
February, 2027 $4.4473 $4.4273 $6.1973 +250.18%
March, 2027 $3.0174 $2.7474 $4.4774 +137.59%
April, 2027 $2.3075 $2.2475 $3.0874 +81.69%
May, 2027 $1.8675 $1.7775 $2.3475 +47.05%
June, 2027 $1.4676 $1.4076 $1.9286 +15.56%
July, 2027 $2.3677 $1.3876 $2.9277 +86.43%
August, 2027 $1.6778 $1.6578 $2.6177 +32.11%
September, 2027 $1.4178 $1.3478 $1.9578 +11.64%
October, 2027 $1.5379 $1.3379 $1.5779 +21.09%
November, 2027 $1.808 $1.448 $1.808 +42.36%
December, 2027 $1.668 $1.518 $1.933 +31.34%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2028

In 2028, Clearside Biomedical Inc (CLSD) is projected to reach an average price of $1.4536, with a high projection of $1.9285 and a low estimate of $0.9787. This indicates an +14.45% rise from the last price of $1.27.
Month Average Low High Change from today's price
January, 2028 $1.4381 $1.3881 $1.6781 +13.24%
February, 2028 $1.2082 $1.0782 $1.4681 -4.87%
March, 2028 $1.2183 $1.0982 $1.4982 -4.07%
April, 2028 $1.2583 $1.1883 $1.6883 -0.92%
May, 2028 $1.2184 $1.0584 $1.3584 -4.06%
June, 2028 $1.5785 $1.1184 $1.8984 +24.29%
July, 2028 $1.3985 $1.361 $1.9285 +10.12%
August, 2028 $1.1586 $1.1386 $1.4986 -8.77%
September, 2028 $1.3187 $0.9787 $1.5587 +3.83%
October, 2028 $1.0887 $0.9905 $1.3287 -14.27%
November, 2028 $1.2288 $1.0788 $1.2687 -3.24%
December, 2028 $1.1989 $1.1789 $1.6189 -5.60%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2029

The 2029 price forecast for Clearside Biomedical Inc Stock (CLSD) is $1.4644 on average, with a high prediction of $2.1996 and a low estimate of $0.7293. This represents an +15.31% increase from the previous price of $1.27.
Month Average Low High Change from today's price
January, 2029 $1.249 $1.1089 $1.3788 -1.66%
February, 2029 $1.019 $0.999 $1.269 -19.76%
March, 2029 $0.9041 $0.9041 $1.039 -28.81%
April, 2029 $0.9401 $0.8991 $0.9891 -25.97%
May, 2029 $1.0475 $0.7293 $1.2692 -17.52%
June, 2029 $1.1093 $0.9578 $1.1393 -12.65%
July, 2029 $1.2494 $1.0036 $1.3393 -1.63%
August, 2029 $1.3294 $1.1794 $1.6144 +4.68%
September, 2029 $1.4395 $1.2495 $1.5395 +13.35%
October, 2029 $1.7896 $1.3795 $2.1996 +40.91%
November, 2029 $1.3896 $1.1796 $1.8596 +9.42%
December, 2029 $1.345 $1.31 $1.5597 +5.91%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2030

Clearside Biomedical Inc Stock (CLSD) is expected to reach an average price of $2.4955 in 2030, with a high forecast of $4.2764 and a low forecast of $0.7145. This signifies an +96.49% surge from the last price of $1.27.
Month Average Low High Change from today's price
January, 2030 $1.1952 $1.1026 $1.46 -5.89%
February, 2030 $1.3503 $1.1103 $1.3703 +6.32%
March, 2030 $1.2154 $1.2004 $1.3503 -4.30%
April, 2030 $0.7572 $0.7145 $1.5404 -40.37%
May, 2030 $0.7807 $0.7206 $1.0956 -38.53%
June, 2030 $1.0758 $0.7507 $1.2108 -15.29%
July, 2030 $1.301 $1.0758 $1.5315 +2.44%
August, 2030 $2.5611 $1.3113 $3.0011 +101.66%
September, 2030 $2.3613 $1.9334 $4.1012 +85.93%
October, 2030 $2.6564 $2.1013 $4.2764 +109.17%
November, 2030 $2.1415 $1.9218 $3.4515 +68.62%
December, 2030 $1.7217 $1.2517 $2.1216 +35.56%
$358.35
price down icon 0.05%
$21.90
price up icon 4.86%
$224.51
price up icon 2.79%
$66.83
price up icon 1.64%
$118.77
price up icon 0.47%
$542.08
price up icon 1.11%
Cap:     |  Volume (24h):